Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristina Larsson

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Orphanet Journal of Rare Diseases|February 18, 2017
Are products with an orphan designation for oncology indications different from products for other rare indications? A retrospective analysis of European orphan designations granted between 2002-2012Kim Pauwels, Isabelle Huys, Minne Casteels, et al.
Frontiers in Medicine|June 1, 2017
Advanced Therapy Medicinal Products for Rare Diseases: State of Play of Incentives Supporting Development in EuropeAndreas M Farkas, Segundo Mariz, Violeta Stoyanova-Beninska, et al.
The International Journal of Behavioral Nutrition and Physical Activity|September 9, 2021
Effects of a three-armed randomised controlled trial using self-monitoring of daily steps with and without counselling in prediabetes and type 2 diabetes-the Sophia Step StudyJenny Rossen, Kristina Larsson, Maria Hagströmer, et al.
Clinical Immunology (Orlando, Fla.)|June 28, 2008
Augmented Phl p 5-specific Th2 response after exposure of dendritic cells to allergen in complex with specific IgE compared to IgG1 and IgG4Kristina Lundberg, Malin Lindstedt, Kristina Larsson, et al.
International Archives of Allergy and Immunology|November 27, 2008
CD4+ T cells have a key instructive role in educating dendritic cells in allergyKristina Larsson, Malin Lindstedt, Kristina Lundberg, et al.
Drug Discovery Today|June 26, 2017
Establishing rarity in the context of orphan medicinal product designation in the European UnionStelios Tsigkos, Matthias Philipp Hofer, Maria Elzbieta Sheean, et al.
Orphanet Journal of Rare Diseases|November 8, 2018
Recommendations for the design of small population clinical trialsSimon Day, Anneliene Hechtelt Jonker, Lilian Pek Lian Lau, et al.
Drug Discovery Today|October 13, 2017
Demonstrating significant benefit of orphan medicines: analysis of 15 years of experience in EuropeLaura Fregonese, Lesley Greene, Matthias Hofer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 22, 2010
Niemann-Pick C1 modulates hepatic triglyceride metabolism and its genetic variation contributes to serum triglyceride levelsRiikka-Liisa Uronen, Per Lundmark, Marju Orho-Melander, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|January 1, 2008
Two methylenetetrahydrofolate reductase gene (MTHFR) polymorphisms, schizophrenia and bipolar disorder: an association studyErik G Jönsson, Kristina Larsson, Maria Vares, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Orphanet Journal of Rare Diseases|February 18, 2017
Are products with an orphan designation for oncology indications different from products for other rare indications? A retrospective analysis of European orphan designations granted between 2002-2012Kim Pauwels, Isabelle Huys, Minne Casteels, et al.
Frontiers in Medicine|June 1, 2017
Advanced Therapy Medicinal Products for Rare Diseases: State of Play of Incentives Supporting Development in EuropeAndreas M Farkas, Segundo Mariz, Violeta Stoyanova-Beninska, et al.
The International Journal of Behavioral Nutrition and Physical Activity|September 9, 2021
Effects of a three-armed randomised controlled trial using self-monitoring of daily steps with and without counselling in prediabetes and type 2 diabetes-the Sophia Step StudyJenny Rossen, Kristina Larsson, Maria Hagströmer, et al.
Clinical Immunology (Orlando, Fla.)|June 28, 2008
Augmented Phl p 5-specific Th2 response after exposure of dendritic cells to allergen in complex with specific IgE compared to IgG1 and IgG4Kristina Lundberg, Malin Lindstedt, Kristina Larsson, et al.
International Archives of Allergy and Immunology|November 27, 2008
CD4+ T cells have a key instructive role in educating dendritic cells in allergyKristina Larsson, Malin Lindstedt, Kristina Lundberg, et al.
Drug Discovery Today|June 26, 2017
Establishing rarity in the context of orphan medicinal product designation in the European UnionStelios Tsigkos, Matthias Philipp Hofer, Maria Elzbieta Sheean, et al.
Orphanet Journal of Rare Diseases|November 8, 2018
Recommendations for the design of small population clinical trialsSimon Day, Anneliene Hechtelt Jonker, Lilian Pek Lian Lau, et al.
Drug Discovery Today|October 13, 2017
Demonstrating significant benefit of orphan medicines: analysis of 15 years of experience in EuropeLaura Fregonese, Lesley Greene, Matthias Hofer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 22, 2010
Niemann-Pick C1 modulates hepatic triglyceride metabolism and its genetic variation contributes to serum triglyceride levelsRiikka-Liisa Uronen, Per Lundmark, Marju Orho-Melander, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|January 1, 2008
Two methylenetetrahydrofolate reductase gene (MTHFR) polymorphisms, schizophrenia and bipolar disorder: an association studyErik G Jönsson, Kristina Larsson, Maria Vares, et al.
Pageof 5